Publications by authors named "Poorva M Nemlekar"
Introduction: Some people with type 2 diabetes (T2D) require intensive insulin therapy to manage their diabetes. This can increase the risk of diabetes-related hospitalizations. We hypothesize that initiation of real-time continuous glucose monitoring (RT-CGM), which continuously measures a user's glucose values and provides threshold- and trend-based alerts, will reduce diabetes-related emergency department (ED) and inpatient hospitalizations and concomitant costs.
View Article and Find Full Text PDFArticle Synopsis
- Patients with diabetes and chronic kidney disease (CKD) are at increased risk for fluctuating blood sugar levels, which can lead to serious health issues requiring hospitalization.
- A study analyzed data on insulin-dependent type 2 diabetes patients with stage 3-5 CKD who began using continuous glucose monitoring (CGM) to manage their condition.
- Results indicated that after starting CGM, hospitalization rates linked to extreme blood sugar levels significantly decreased, showing the potential benefits of CGM for this patient demographic.
Article Synopsis
- Continuous glucose monitoring (CGM) improves glycemic outcomes for diabetes patients, but adherence levels and their impact on outcomes are not fully understood.
- A study analyzed data from 7,669 individuals with type 1 or type 2 diabetes who started using either intermittent scanned (isCGM) or real-time CGM (rtCGM) over 12 months.
- Results showed that rtCGM users had significantly higher adherence rates and better A1C reductions compared to isCGM users, indicating that commitment to CGM usage is crucial for managing blood sugar levels effectively.
Article Synopsis
- The study looked at the impact of professional continuous glucose monitoring (p-CGM) on A1C levels in patients with type 2 diabetes who weren’t using insulin.
- It included data from 15,481 patients, finding that those using p-CGM experienced a greater decrease in A1C levels compared to those who didn’t use it, regardless of any insulin use later on.
- The results suggest that p-CGM can be beneficial for improving glycemic control in type 2 diabetes patients using multiple noninsulin treatments over a 6-month period.